Argos Therapeutics Inc (ARGS) - Financial and Strategic SWOT Analysis Review

  • ID: 4284919
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Argos Therapeutics
1 of 4

Argos Therapeutics Inc (Argos) is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platform. Its Arcelis-based immunotherapies use the patient’s dendritic cells to activate an immune response specific to the patient’s disease. Argos also offers AGS-003 for the treatment of metastatic renal cell carcinoma, or mRCC, and AGS-004 for the treatment of HIV. The company use biology of dendritic cells to develop novel technologies with applications for organ and tissue transplantation and inflammatory and the treatment of autoimmune disorders. Argos is headquartered in Durham, North Carolina, the US.

Argos Therapeutics Inc Key Recent Developments

Feb 05, 2018: Argos Obtains Option to License PD1 Checkpoint Inhibitors
Nov 28, 2017: Argos Provides Financial Update
Nov 09, 2017: Argos Reports Third Quarter 2017 Financial Results and Operational Highlights
Sep 26, 2017: Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors
Aug 09, 2017: Argos Therapeutics Reports Second Quarter 2017 Financial Results and Recent Operational Highlights

This comprehensive SWOT profile of Argos Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Argos Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Argos Therapeutics Inc - Key Information
  • Argos Therapeutics Inc - Overview
  • Argos Therapeutics Inc - Key Employees
  • Argos Therapeutics Inc - Key Employee Biographies
  • Argos Therapeutics Inc - Key Operational Heads
  • Argos Therapeutics Inc - Major Products and Services
  • Argos Therapeutics Inc - History
  • Argos Therapeutics Inc - Company Statement
  • Argos Therapeutics Inc - Locations And Subsidiaries
  • Argos Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Argos Therapeutics Inc - Business Description
  • Argos Therapeutics Inc - Corporate Strategy
  • Argos Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Argos Therapeutics Inc - Strengths
  • Argos Therapeutics Inc - Weaknesses
  • Argos Therapeutics Inc - Opportunities
  • Argos Therapeutics Inc - Threats
  • Argos Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Argos Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Argos Therapeutics Inc, Key Information
  • Argos Therapeutics Inc, Key Ratios
  • Argos Therapeutics Inc, Share Data
  • Argos Therapeutics Inc, Major Products and Services
  • Argos Therapeutics Inc, History
  • Argos Therapeutics Inc, Key Employees
  • Argos Therapeutics Inc, Key Employee Biographies
  • Argos Therapeutics Inc, Key Operational Heads
  • Argos Therapeutics Inc, Other Locations
  • Argos Therapeutics Inc, Subsidiaries
  • Argos Therapeutics Inc, Key Manufacturing facilities
  • Argos Therapeutics Inc, Key Competitors
  • Argos Therapeutics Inc, SWOT Analysis
  • Argos Therapeutics Inc, Ratios based on current share price
  • Argos Therapeutics Inc, Annual Ratios
  • Argos Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Argos Therapeutics Inc, Performance Chart
  • Argos Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown